Syndax Pharmaceuticals Inc (NASDAQ: SNDX) announced topline data from the AUGMENT-101 trial of revumenib in adult and pediatric patients with relapsed/refractory (R/R) KMT2A-rearranged (KMT2Ar) acute myeloid leukemia (AML) and
Enbridge increased its 2023 quarterly dividend by 3.2% to $0.8875 ($3.55 annualized) per share, commencing with the dividend payable on March 1, 2023 to shareholders of record on February 15, 2023.
The NFT Gaming Company, Inc. ("NFTG" or the "Company"), a company developing a digital gaming platform and community that will offer users the ability to create unique avatars playable in all of the games on the platform